VC-backed Codiak Biosciences goes public
Codiak Biosciences Inc, a developer of exosome-based therapeutics, has raised about $82.5 million for its IPO after pricing its 5.5 million shares at $15 per share.
Codiak Biosciences Inc, a developer of exosome-based therapeutics, has raised about $82.5 million for its IPO after pricing its 5.5 million shares at $15 per share.
Copyright PEI Media
Not for publication, email or dissemination